DAPIROLIZUMAB PEGOL
UNII N4606MB5HM

Substance Identification & Data

This profile provides standardized clinical and technical data for Dapirolizumab Pegol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N4606MB5HM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1416147-64-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
N4606MB5HM
CAS Registry Number
1416147-64-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DAPIROLIZUMAB PEGOL
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C174737
National Cancer Institute reference terminology for clinical and research data.
INN ID
9869
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dapirolizumab Pegol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DAPIROLIZUMAB PEGOL

Common Names & Synonyms

CDP-7657
DAPIROLIZUMAB PEGOL [INN]
DAPIROLIZUMAB PEGOL [WHO-DD]
IMMUNOGLOBULIN FAB' G1-KAPPA PEGYLATED, ANTI-(HOMO SAPIENS CD40LG (CD40 LIGAND, CD40L, TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 5, TNFSF5, TUMOR NECROSIS FACTOR RELATED ACTIVATION PROTEIN, TRAP, CD154)), PEGYLATED HUMANIZED MONOCLONAL ANTIBODY

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus